Tefenperate

This classification denotes an antihypertensive agent with the molecular formula C29H37Cl2NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5P145L26T, chemically known as 2-(2,2,6,6-tetramethylpiperidino)ethyl 2-chlor-alpha-(2-chlorbenzyl)-alpha-hydroxyhydrocinnamat acetat but generally known as tefenperate, which bears US NIH Compound Identifier 163310. European Medicines Agency schedules Tefenperate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10866MIG. The term TEFENPERATE is an International Non-Proprietary Name. TEFENPERATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefenperate under HS 29333999 and SITC 51574. As of Q4 2014, TEFENPERATE remains the US FDA Preferred Term for this commodity. Tefenperate bears US NLM identifiers UMLS ID C2699907 and NCI Concept Code C75241. SMILES: Clc1c(CC(OC(=O)C)(C(=O)OCCN2C(CCCC2(C)C)(C)C)Cc2c(Cl)cccc2)cccc1.